Euclid Advisors’s Humana HUM Stock Holding History

Euclid Advisors’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-14,572	Closed	-$2.62M	–	229
2016 Q2	$2.62M	Buy	14,572 +400	+3%	+$71.1K	0.11%	243
2016 Q1	$2.59M	Sell	14,172 -19,928	-58%	-$3.46M	0.1%	251
2015 Q4	$6.09M	Sell	34,100 -770	-2%	-$135K	0.19%	167
2015 Q3	$6.24M	Sell	34,870 -13,312	-28%	-$2.46M	0.28%	117
2015 Q2	$9.22M	Sell	48,182 -10,548	-18%	-$1.96M	0.18%	180
2015 Q1	$10.5M	Buy	+58,730	New	+$9.3M	0.19%	133
2014 Q4	–	Sell	-84,210	Closed	-$11M	–	433
2014 Q3	$11M	Buy	84,210 +5,040	+6%	+$641K	0.08%	232
2014 Q2	$10.1M	Sell	79,170 -12,300	-13%	-$1.46M	0.07%	263
2014 Q1	$10.3M	Buy	91,470 +24,350	+36%	+$2.54M	0.08%	230
2013 Q4	$6.93M	Sell	67,120 -4,250	-6%	-$416K	0.06%	295
2013 Q3	$6.66M	Buy	71,370 +14,860	+26%	+$1.36M	0.07%	267
2013 Q2	$4.77M	Buy	+56,510	New	+$4.46M	0.06%	305

Other funds holding HUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

ETC

Evercore Trust Company New York $34.6B AUM 25.41% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Euclid Advisors's HUM Position: Q3 2016 in Review

Euclid Advisors sold out of Humana (HUM) in Q3 2016, closing a stake of 14,572 shares — an estimated $2.62M sold.

Euclid Advisors first reported a position in HUM in Q2 2013 and held it in 12 quarters. The position peaked at $11M in Q3 2014. 570 funds tracked by Wall St. Rank hold HUM as of Q3 2016.

Euclid Advisors reported no remaining Humana position as of Q3 2016 after selling out during the quarter.
Euclid Advisors sold 14,572 Humana shares in Q3 2016, an estimated $2.62M.
Euclid Advisors first reported a position in Humana in Q2 2013 and held it in 12 quarters.
Euclid Advisors's Humana position peaked at $11M in Q3 2014.
570 funds tracked by Wall St. Rank held Humana as of Q3 2016.

Based on Euclid Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.